Showing results 9 to 25 of 25
< previous
Issue Date | Title | Author(s) |
2011-09-01 | Epithelial profiling of antibiotic controlled release respiratory formulations | Ong, HX; Traini, D; Bebawy, M; Young, PM |
2021-08-05 | How Do Mechanics Guide Fibroblast Activity? Complex Disruptions during Emphysema Shape Cellular Responses and Limit Research. | Leslie, MN; Chou, J; Young, PM; Traini, D; Bradbury, P; Ong, HX |
2014-01-01 | In vitro and ex vivo methods predict the enhanced lung residence time of liposomal ciprofloxacin formulations for nebulisation | Ong, HX; Benaouda, F; Traini, D; Cipolla, D; Gonda, I; Bebawy, M; Forbes, B; Young, PM |
2012-01 | Inhaled Liposomal Ciprofloxacin Nanoparticles Control the Release of Antibiotic at the Bronchial Epithelia | Ong, HX; Cipolla, DC; Gonda, I; Traini, D; Bebawy, M; Agus, H; Young, PM; Dalby, RN; Byron, PR; Peart, J; Suman, JD; Farr, SJ; Young, PM |
2012-12-01 | Liposomal nanoparticles control the uptake of ciprofloxacin across respiratory epithelia | Ong, HX; Traini, D; Cipolla, D; Gonda, I; Bebawy, M; Agus, H; Young, PM |
2020-01 | Modifying and Integrating <i>in vitro</i> and <i>ex vivo</i> Respiratory Models for Inhalation Drug Screening. | Cidem, A; Bradbury, P; Traini, D; Ong, HX |
2013-08-01 | Multiple dosing of simvastatin inhibits airway mucus production of epithelial cells: Implications in the treatment of chronic obstructive airway pathologies | Marin, L; Traini, D; Bebawy, M; Colombo, P; Buttini, F; Haghi, M; Ong, HX; Young, P |
2022-02-22 | Nanoparticle Delivery Platforms for RNAi Therapeutics Targeting COVID-19 Disease in the Respiratory Tract. | Zhang, Y; Almazi, JG; Ong, HX; Johansen, MD; Ledger, S; Traini, D; Hansbro, PM; Kelleher, AD; Ahlenstiel, CL |
2014-01 | Optimization of RPMI 2650 Cells as a Model for Nasal Mucosa | Pozzoli, M; Sonvico, F; Ong, HX; Traini, D; Bebawy, M; Young, P; Dalby, RN; Byron, PR; Peart, J; Suman, JD; Farr, SJ; Young, PM; Traini, D |
2020-08-21 | Properties of rapamycin solid lipid nanoparticles for lymphatic access through the lungs & part I: the effect of size. | Landh, E; M Moir, L; Bradbury, P; Traini, D; M Young, P; Ong, HX |
2023-03 | Real-time in-situ electrochemical monitoring of Pseudomonas aeruginosa biofilms grown on air-liquid interface and its antibiotic susceptibility using a novel dual-chamber microfluidic device. | Zhang, Y; Gholizadeh, H; Young, P; Traini, D; Li, M; Ong, HX; Cheng, S |
2021-06 | Real-time quantitative monitoring of in vitro nasal drug delivery by a nasal epithelial mucosa-on-a-chip model. | Gholizadeh, H; Ong, HX; Bradbury, P; Kourmatzis, A; Traini, D; Young, P; Li, M; Cheng, S |
2018-08-01 | Repurposing of statins via inhalation to treat lung inflammatory conditions | Bradbury, P; Traini, D; Ammit, AJ; Young, PM; Ong, HX |
2020-01-02 | A review of respiratory anatomical development, air flow characterization and particle deposition | Islam, MS; Paul, G; Ong, HX; Young, PM; Gu, YT; Saha, SC |
2023-05 | The development of a 3D-printed in vitro integrated oro-pharyngeal air-liquid interface cellular throat model for drug transport. | Sheikh, Z; Granata, A; Zhang, Y; Mahvizani, HMG; Silva, D; Young, PM; Casettari, L; Ong, HX; Traini, D |
2022-06 | Timothy Grass Pollen Induces Spatial Reorganisation of F-Actin and Loss of Junctional Integrity in Respiratory Cells. | Bradbury, P; Cidem, A; Mahmodi, H; Davies, JM; Spicer, PT; Prescott, SW; Kabakova, I; Ong, HX; Traini, D |
2021-07-05 | Tobramycin and Colistin display anti-inflammatory properties in CuFi-1 cystic fibrosis cell line. | Sheikh, Z; Bradbury, P; Reekie, TA; Pozzoli, M; Robinson, PD; Kassiou, M; Young, PM; Ong, HX; Traini, D |